scholarly journals Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies

2010 ◽  
Vol 46 (2) ◽  
pp. 340-347 ◽  
Author(s):  
Shivaani Kummar ◽  
Martin E. Gutierrez ◽  
Erin R. Gardner ◽  
Xiaohong Chen ◽  
William D. Figg ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Phase I ◽  
Phase I Trial ◽  
Protein Inhibitor ◽  
Advanced Malignancies

Phase I trial of OGX-427, a 2'methoxyethyl antisense oligonucleotide (ASO), against heat shock protein 27 (Hsp27): Final results.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3077-3077 ◽  
Author(s):  
S. J. Hotte ◽  
E. Y. Yu ◽  
H. W. Hirte ◽  
C. S. Higano ◽  
M. E. Gleave ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Phase I ◽  
Antisense Oligonucleotide ◽  
Phase I Trial ◽  
Heat Shock Protein 27

STA-4783 in combination with paclitaxel induces heat shock protein 70 (hsp70) in a phase I trial

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2011-2011 ◽  
Author(s):  
A. Berkenblit ◽  
J. Supko ◽  
D. P. Ryan ◽  
M. V. Seiden ◽  
M. Nagai ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Phase I ◽  
Heat Shock Protein 70 ◽  
Phase I Trial

The heat shock protein inhibitor KNK437 induces neurite outgrowth in PC12 cells

2006 ◽  
Vol 410 (3) ◽  
pp. 212-217 ◽  
Author(s):  
Tomoko Koike ◽  
Shigeyuki Uno ◽  
Michiyasu Ishizawa ◽  
Hideo Takahashi ◽  
Kazumasa Ikeda ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Neurite Outgrowth ◽  
Pc12 Cells ◽  
Protein Inhibitor

scholarly journals A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

2011 ◽  
Vol 17 (6) ◽  
pp. 1561-1570 ◽  
Author(s):  
Simon Pacey ◽  
Richard H. Wilson ◽  
Mike Walton ◽  
Martin M. Eatock ◽  
Anthea Hardcastle ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Heat Shock Protein 90 ◽  
Advanced Solid Tumors

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

2007 ◽  
Vol 13 (4) ◽  
pp. 1232-1237 ◽  
Author(s):  
R. J. Morgan ◽  
T. W. Synold ◽  
B. Xi ◽  
D. Lim ◽  
S. Shibata ◽  
...  
Keyword(s):  
Phase I ◽  
Peritoneal Cavity ◽  
Phase I Trial ◽  
Advanced Malignancies

scholarly journals Phase I Trial of Intraperitoneal Nab-Paclitaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

2014 ◽  
Vol 25 ◽  
pp. iv159
Author(s):  
M.C. Cristea ◽  
S. Rivkin ◽  
D. Lim ◽  
V. Chung ◽  
J. Chao ◽  
...  
Keyword(s):  
Phase I ◽  
Peritoneal Cavity ◽  
Phase I Trial ◽  
Advanced Malignancies

Phase I Trial of Piritrexim Capsules Using Prolonged, Low-Dose Oral Administration for the Treatment of Advanced Malignancies

1991 ◽  
Vol 83 (1) ◽  
pp. 51-55 ◽  
Author(s):  
L. G. Feun ◽  
N. Savaraj ◽  
P. Benedetto ◽  
J. Hanlon ◽  
K. S. Sridhar ◽  
...  
Keyword(s):  
Oral Administration ◽  
Phase I ◽  
Phase I Trial ◽  
Low Dose ◽  
Advanced Malignancies ◽  
Dose Oral
Sign in / Sign up

Export Citation Format

Share Document